Z. A. Shabeeb, Y. F. Faraj, B. A. Mtashar, M. S. Hussein, and A. F. Hasan, “Immune-biomarker signature predicts early molecular response in Iraqi chronic myeloid leukemia patients receiving front-line tyrosine-kinase inhibitors”, Regul. Mech. Biosyst., vol. 16, no. 4, p. e25197, Dec. 2025.